Basilea in Talks with J J Over Antibiotic  ZURICH (Reuters) - Switzerland's Basilea is in talks with a  subsidiary of healthcare and consumer products maker Johnson    Johnson over a licensing agreement for the Swiss biotech firm's  BAL5788 antibiotic.